US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
AMEX
Sachem Capital Corporation (SACH-A) 銘柄情報

Sachem Capital Corporation (SACH-A)

20.39

0.07

(0.344488%)

終了 7月13日 5:00AM

20.39

0.00

(0.00%)

取引時間後: 8:55AM

Sachem Capital Corporation (SACH-A) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

20.39

( 0.34% )

買値

-

売値

-

出来高

532

平均取引量 (3 か月)

US$ 462,520

財務取引量

US$ 10,847

20.28 日の範囲 20.39

0.00 52 週間の範囲 0.00

時価総額

企業価値

-

前日終値

20.32

始値

20.28

時刻

最終取引時間

VWAP

20.39

歳入

14.69M

純利益

-673k

発行済株式数

47,955,647

浮動株比率 (%)

94.54%

機関投資家保有比率 (%)

18.68%

配当利回り

0.2 (16.67%)

PER

-8.59

株価売上高倍率 (PSR)

3.07

1 株当たり利益 (EPS)

-0.11

ベータ

1.18

Sachem Capital Corp. operates as a real estate finance company in the United States. It engages in the originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property. The company also offers non-bank loans. It serves real ... Sachem Capital Corp. operates as a real estate finance company in the United States. It engages in the originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property. The company also offers non-bank loans. It serves real estate investors and developers to fund their acquisition, renovation, rehabilitation, development, and improvement of residential or commercial properties. The company was formerly known as HML Capital Corp. and changed its name to Sachem Capital Corp. in December 2016. Sachem Capital Corp. was founded in 2010 and is headquartered in Branford, Connecticut. 詳細を表示

セクター

Financials

業界

Mortgage Real Estate Investment Trusts (reits)

ウェブサイト

www.sachemcapitalcorp.com

本社

Branford, United States

設立

2026

Sachem Capital Corporation is listed in the Financials sector of the アメリカ証券取引所 with ticker SACH-A. The last closing price for Sachem Capital was US$20.32. Over the last year, Sachem Capital shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Sachem Capital currently has 47,955,647 shares in issue. The market capitalisation of Sachem Capital is US$977.82 million. Sachem Capital has a price to earnings ratio (PE ratio) of -8.59.

Form 8-K - Current report

Form ARS - Annual Report to Security Holders

Form DEF 14A - Other definitive proxy statements

Form 3 - Initial statement of beneficial ownership of securities

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	PR
4	0	0	0	0	0	0	0	PR
12	0	0	0	0	0	0	0	PR
26	0	0	0	0	0	0	0	PR
52	0	0	0	0	0	0	0	PR
156	0	0	0	0	0	0	0	PR
260	0	0	0	0	0	0	0	PR

SACH-A - Frequently Asked Questions (FAQ)

What is the current Sachem Capital Corporation share price?

The current share price of Sachem Capital Corporation is US$ 20.39

How many Sachem Capital Corporation shares are in issue?

Sachem Capital Corporation has 47,955,647 shares in issue

What is the market cap of Sachem Capital Corporation?

The market capitalisation of Sachem Capital Corporation is USD 977.82M

What is the 1 year trading range for Sachem Capital Corporation share price?

Sachem Capital Corporation has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Sachem Capital Corporation?

The price to earnings ratio of Sachem Capital Corporation is -8.59

What is the cash to sales ratio of Sachem Capital Corporation?

The cash to sales ratio of Sachem Capital Corporation is 3.07

What is the registered address of Sachem Capital Corporation?

The registered address for Sachem Capital Corporation is 568 East Main Street, Branford, Connecticut, 06405

What is the Sachem Capital Corporation website address?

The website address for Sachem Capital Corporation is www.sachemcapitalcorp.com

Which industry sector does Sachem Capital Corporation operate in?

Sachem Capital Corporation operates in the Mortgage Real Estate Investment Trusts (REITs) sector

Truthsocial

Truthsocial 4分前

Yes, preliminary trial results for Vivos Inc (RDGL) in India are available and have been publicly reported, but comprehensive final data is still pending.

Safety and Efficacy Data: Reports from early 2025 confirm that ten patients with cancerous lymph nodes were successfully treated

Biotech_Tradez

Biotech_Tradez 7分前

Heard Electrome was not happy with Mayer on a number of different fronts.

They were not very keen on this deal with BIEL because it is a distraction from what they are doing with their own patent-pending device that was invented by the new CEO. He is taking it to DARPA for funding. On

shajandr

shajandr 14分前

SAM ALTMAN = LIZZY HOLMES with better hair.

ron_66271

ron_66271 17分前

The Discovery Document by QE Proves RICO.

Project West.

The BOD was reviewed on the status of the project three times from the discovery document.
Therefore the BOD past and present are compliant if current members have not voiced their concerns about settlement

Porch Honkey

Porch Honkey 20分前

When they are ready, there will be investors here that you have never seen before, gl.

LOB

Blaqclouds Wyoming

@blaqclouds_WY
#Blaqclouds • #DEFI💎 http://BLAQpay.io http://AplloNFT.io🔎• #NFT #WEB3 Dev • DM 📩 for Collab
Social Media InfluencerPAblaqclouds.io
Joined May 2020
1,260 Following
123.5K Followers

Juststoppingby

Juststoppingby 25分前

My AI responds to clarification on “EDGAR packages are being validated”.

When I say “EDGAR packages are being validated,” I’m talking about a very specific, very technical stage in the SEC-filing process — one that happens right before a delinquent filer begins submitting forms.

zakattack

zakattack 26分前

They put out a pr dec 2025 stating they would increase to 49% in gncp but no filings proving they actually did so sp again where is the proof pdiv paid anything or did anything for the land claims prove me wrong

nowwhat2

nowwhat2 29分前

xxxxxxxxxxxx wow

https://investorshub.advfn.com/uimage/uploads/2026/7/13/i[smibtc_july_12_2m_7pm_200_64_diag_point.jpg

https://investorshub.advfn.com/uimage/uploads/2026/7/13/wtzkebtc_july_12_2m_9pm_update_200_64_point_tl.jpg

mikeo56

mikeo56 31分前

Smoking in Aussie land .
Up 30 %
Tomorrow in USA will be good.

choo choo trader

choo choo trader 34分前

Thanks for reposting it Striper, somehow I missed it when gdog initially posted it. That is about the most informative video I have seen so far laying out the whole risk/reward story of $NLST.

ron_66271

ron_66271 35分前

No The FDIC and JPM both Had a Claim Against $24 Billion.

Inflated claim of $27*2=$54.00 Billion against the Estate to make WMI as insolvent for the Senior Note holders when JPM controlled the BK process because invested in the Senior Notes of WMI with the takeover.

skitahoe

skitahoe 35分前

Doc, I've been saying this for ages, but not that the full EDEN based facility must be completed. I believe the UK and other countries would simply like to know it's close. They'd like to know the EDEN is making commercial quality vaccine and that it can be delivered in quantity, and they'd like t

FDA-agent-2

FDA-agent-2 39分前

nobody is getting paid here .no editiing or no research which cost money.

Johnnycombat10

Johnnycombat10 40分前

I see both sides of the debate . The company has every right to state their position just as you have your right to speak yours. But you have right to demand anything from anyone on this board. You have no rights other than the right to speak our mind. And I have the to tell you to pound salt. If I

AstroGuru64

AstroGuru64 41分前

The issue still lies with the Treasury Department.

FDA-agent-2

FDA-agent-2 44分前

too much fake news on facebook, yahoo,and youtube these. and tabloid news or censored news.
sites like google, yahoo. facebook cannot get the content for cheap anymore or they won't even license it to them, it used to be free or very cheap to promote their newsight but they don't nobody ever

Truthsocial

Truthsocial 47分前

Vivos Inc. received U.S. FDA approval for the Investigational Device Exemption (IDE) for RadioGel® on July 6, 2026, which permits the initiation of the first-in-human feasibility study at Mayo Clinic in Jacksonville, FL.

While the FDA IDE approval has been granted, the study protocol

gfp927z

gfp927z 47分前

New York Times - >>> In the fourth quarter of 2025, Berkshire Hathaway acquired about 5.1 million shares of The New York Times Company, taking a roughly 3% stake valued at $350–$352 million. This was the first time Berkshire had invested in a newspaper since selling off its holdings in 2020. The mov

uber darthium

uber darthium 47分前

DBSCAM’em

A Linda Poory SCAM for over 2 decades

Can’t wait to read that filing this week

Ought to make for some good SCAM reading

DBSCAM’em

Noted and Always Correct

zerosnoop

zerosnoop 48分前

All the GEMS & FACTS are in the latest 10Q filing. The PROVEN AOT is going GLOBAL.

We are now focusing on a potential sale of 150 units as an initial purchase order under the so-called Laksel LOI (discussed below). This represents a defined India focused initial program wit

gfp927z

gfp927z 49分前

New York Times - >>> In the fourth quarter of 2025, Berkshire Hathaway acquired about 5.1 million shares of The New York Times Company, taking a roughly 3% stake valued at $350–$352 million. This was the first time Berkshire had invested in a newspaper since selling off its holdings in 2020. The mov

raggi65

raggi65 50分前

Do you have a link to the discovery document filed by Quinn Emanuel?
825 pages – that sounds as though there might be plenty of useful arguments in there, and with a citable reference, they would be all the more compelling

juicyjuice10002

juicyjuice10002 52分前

Yes, Executive Order 14393 is widely expected to help Fannie Mae (FNMA) and Freddie Mac (FMCC) by laying the regulatory groundwork for their eventual exit from government conservatorship.

While much of the public text targets community banks, the order contains specific directives fo

Emirates Ab 23s

BlackRock Institutional ...

1399 Internet Technology... (ID)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。